| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |